Cervical biopsy/cytology correlation data can be collected prospectively and shared clinically

Area of Science:

• Gynecologic Pathology
• Cytopathology
• Laboratory Quality Improvement

Background:

• Cervical cytology (Cy) and biopsy (Bx) correlation is a key component of laboratory quality improvement (QI).
• However, correlation data is often not included in surgical pathology (SP) reports, limiting its clinical utility.
• This study evaluates a laboratory protocol for integrating Cy/Bx correlation into gynecologic SP reports.

Purpose of the Study:

• To assess the utility of routine cervical cytology and biopsy correlation within surgical pathology reports.
• To identify and categorize discrepancies, including diagnostic errors and sampling errors.
• To determine the clinical impact of incorporating correlation data into patient management.

Main Methods:

• Reviewed 3,486 gynecologic surgical pathology cases between July 1998 and June 1999.
• Included correlation of the most recent cytology smear in the surgical pathology report.
• Categorized non-correlating cases into major/minor diagnostic errors (DE1/DE2) and sampling errors (Cy SE/Bx SE).

Main Results:

• 86.9% of 3,229 satisfactory cases showed concordant results.
• Diagnostic errors (DE1/DE2) occurred in 1.2% of cases.
• Sampling errors accounted for discrepancies: 6.8% (Bx SE) and 5.1% (Cy SE). Follow-up Bx in Bx SE cases revealed 16.4% major discrepancies.

Conclusions:

• Cervical Cy/Bx correlation is valuable for laboratory QI and identifying diagnostic/sampling errors.
• Incorporating correlation comments (CC) into SP reports is vital for patient-specific management.
• Bx SE in 6.3% of patients highlights the need for potential rebiopsy and informed clinical decisions.